
In this video, Dr Hanauer, from the Feinberg School of Medicine at Northwestern University in Chicago, reviews his presentation at the Crohn's & Colitis Congress 2021 on "evolutionary" agents on the horizon for treatment of inflammatory bowel disease.
Dr Cohen, director of the IBD Center at the University of Chicago, recaps his presentation at the Crohn's & Colitis Congress 2021 on using novel small molecule agents to treat inflammatory bowel disease.
Dr Brenner discusses her presentation at the Crohn's & Colitis Congress on what data indicate about the risks and disease course of pediatric patients with inflammatory bowel disease during the COVID-19 pandemic.
In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in direct care for patients with inflammatory…
Marla Dubinsky, MD, and Asher Kornbluth, MD, both from the Icahn School of Medicine at Mount Sinai in New York City, discuss the latest updates on COVID-19 vaccines, recent recommendations from the International Organization of Inflammatory Bowel Diseases, and how they counsel their patients…